BREAKING NEWS

Pfizer secures Allergan takeover deal to create new drugs giant

 Comments
Pfizer secures Allergan takeover deal to create new drugs giant
Euronews logo
Text size Aa Aa

A potent mix of Viagra and Botox is on the cards: their makers have agreed the healthcare sector’s biggest ever takeover deal.

The transaction to combine the two manufacturers has been valued at around $160 billion (150 billion euros).

Last month it was reported that Pfizer and Allergan were in talks over a merger.

Viagra’s manufacturer, the New York-based Pfizer will keep its name – and crucially, may be able to escape the US corporate tax rate of 35 percent – one of the highest in the world.

Instead, by shifting its headquarters to Dublin under a so-called “inversion” deal, the home of Botox maker Allergan, it may see its tax liability plunge.

Ireland’s business tax rate is just 12 and a half percent.

The companies say they expect the deal to be completed in the second half of 2016.

Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.